Airway Medix S.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-09-25
Share capital
39,137,550.96 PLN
Activity description

Airway Medix develops single-use respiratory devices for intensive care, operating rooms and anaesthesia. Its products include the B-Care Oral Care kit and AWM Cuffix cuff pressure regulator; the company is also developing a closed suction system and HyperForm mask.

Registered address
ul. Łucka 15/212, 00-842 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-98401-76952-CWUEI-30

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 105 days for 2023). All were audited by a statutory auditor.

  • 202531/08/2026
  • 202408/10/2025
  • 202328/10/2024
  • 202217/07/2023
  • 202104/07/2022
  • 202009/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.23
-0.00 (-1.50%)
0.230.230.230.230.230.2310:0012:0014:0016:00
Open
PLN 0.23
High
PLN 0.23
Low
PLN 0.23
Volume
82.14K
Avg. vol.
119.42K
Market cap
PLN 26.48M
P/E ratio
–
EPS
-PLN 0.07
Shares outstanding
115.11M
52-week
PLN 0.23 – 0.26
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 15.67kUSD -309.29kUSD -438.14k
Q1 2026USD 22.96kUSD -230.96kUSD -415.72k
Q4 2025USD 1.00kUSD -336.51kUSD -587.14k
Q3 2025USD -2.26kUSD -445.50kUSD -532.65k

Results for Q3 2026:Nov 23, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 7.8%
City · Warszawa8,654 / 56,729
Top 15%
Voivodeship · Mazowieckie12,324 / 76,892
Top 16%
Country · Poland47,682 / 297,069
Top 16%

Results vs industry

Revenue
This companyUSD 2.99mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 438.47kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 1.49mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 3.08mMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Oral care kit
  • Cuff pressure regulator
  • Closed suction system
  • Medical mask
Certifications: ISO 13485

Website technology

Website
  • Next.js

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 3 marks have expired or were not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
Cuffix (word)Z.4654385, 9, 10Protected Dec 20, 2026
SweepAir (word)Z.4654395, 9, 10Not registered –
Airway Medix Z.4383889, 10Expired –
AIRWAY MEDIX (word)Z.4383919, 10Expired –
MarkProtected until
Cuffix (word)Dec 20, 2026
SweepAir (word)–
Airway Medix –
AIRWAY MEDIX (word)–

Authorized Representatives

Alicja Anna Psiuk age 46 – Attorney-in-fact (sole)
Peter Kröner – Management Board Member

Manner of representation

Each member of the management board has the right to represent the company independently.

Supervisory board

Julius Brandt – Supervisory Board Member
Christophe Geisert – Supervisory Board Member
Giuseppe Schembri – Supervisory Board Member
Matthias Kuss – Supervisory Board Member

Beneficial owners

Airway Medix is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Bank accounts

Registered as a VAT taxpayer on 2013-08-19.

  • mBank
    29 1140 1010 0000 3182 9100 1008
  • mBank
    40 1140 1010 0000 3182 9100 1004
  • mBank
    67 1140 1010 0000 3182 9100 1003

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jun 5, 2014Shareholders' meeting convened
Jan 16, 2014Shareholders' meeting convened
Oct 10, 2013Commercial Companies Code notice

Public aid

5 public aid cases recorded, with a total value of $78,539.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
SUMI sp. z o.o. + limited partnership
Extrudan sp. z o.o.
Margomed S.A.
Dina-Hitex Polska sp. z o.o.
Prino-Plast sp. z o.o.
Neoset sp. z o.o.
Steriwund sp. z o.o.
Advance Europe Biuro Techniczno - Handlowe sp. z o.o.
Mustaf Medical sp. z o.o.
Przedsiębiorstwo Produkcyjno-Handlowe Def-Pol sp. z o.o.

Change history

DateEvent
2026-11-05Address change
2025-06-25Share capital increase
2024-06-24Share capital increase
2024-04-18Address change
2024-01-22Share capital increase

FAQ

Last updated: 2026-11-05